diabetes glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists GLP1-GIP receptor co-agonists: a promising
Description
N/A: Not APplicable
This transparent model eliminates hidden markups, where costs might be artificially inflated before being passed to the plan sponsor, and removes the incentive for PBMs to prioritize higher-cost drugs
These drugs work by acting on different hormones that help regulate weight, insulin levels and craving centers in the brain
Y., Peters, T
For a member who is successful in utilizing a GLP-1, the co-therapy requirement is for 24 months
